Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Langley

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 24, 2008
Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitorsKurt Zimmermann, Mark D Wittman, Mark G Saulnier, et al.
Antimicrobial Agents and Chemotherapy|November 17, 2010
In vivo patterns of resistance to the HIV attachment inhibitor BMS-488043Nannan Zhou, Beata Nowicka-Sans, Sharon Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2007
Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R)Upender Velaparthi, Mark Wittman, Peiying Liu, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2019
Heterocycle amide isosteres: An approach to overcoming resistance for HIV-1 integrase strand transfer inhibitorsKevin M Peese, B Narasimhulu Naidu, Manoj Patel, et al.
Journal of Medicinal Chemistry|June 20, 2018
Discovery of the Human Immunodeficiency Virus Type 1 (HIV-1) Attachment Inhibitor Temsavir and Its Phosphonooxymethyl Prodrug FostemsavirTao Wang, Yasu Ueda, Zhongxing Zhang, et al.
Journal of Medicinal Chemistry|January 12, 2016
Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 InhibitorsGuanglin Luo, Ling Chen, Catherine R Burton, et al.
Journal of Virology|September 13, 2003
Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactionsQi Guo, Hsu-Tso Ho, Ira Dicker, et al.
Virology|July 31, 2013
Characterizations of HCV NS5A replication complex inhibitorsDonald R O'Boyle Ii, Jin-Hua Sun, Peter T Nower, et al.
Angewandte Chemie (International Ed. in English)|September 14, 2018
A General Amino Acid Synthesis Enabled by Innate Radical Cross-CouplingShengyang Ni, Alberto F Garrido-Castro, Rohan R Merchant, et al.
Journal of Medicinal Chemistry|February 22, 2020
Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase InhibitorsGuo Li, Nicholas A Meanwell, Mark R Krystal, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|June 24, 2008
Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitorsKurt Zimmermann, Mark D Wittman, Mark G Saulnier, et al.
Antimicrobial Agents and Chemotherapy|November 17, 2010
In vivo patterns of resistance to the HIV attachment inhibitor BMS-488043Nannan Zhou, Beata Nowicka-Sans, Sharon Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2007
Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R)Upender Velaparthi, Mark Wittman, Peiying Liu, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2019
Heterocycle amide isosteres: An approach to overcoming resistance for HIV-1 integrase strand transfer inhibitorsKevin M Peese, B Narasimhulu Naidu, Manoj Patel, et al.
Journal of Medicinal Chemistry|June 20, 2018
Discovery of the Human Immunodeficiency Virus Type 1 (HIV-1) Attachment Inhibitor Temsavir and Its Phosphonooxymethyl Prodrug FostemsavirTao Wang, Yasu Ueda, Zhongxing Zhang, et al.
Journal of Medicinal Chemistry|January 12, 2016
Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 InhibitorsGuanglin Luo, Ling Chen, Catherine R Burton, et al.
Journal of Virology|September 13, 2003
Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactionsQi Guo, Hsu-Tso Ho, Ira Dicker, et al.
Virology|July 31, 2013
Characterizations of HCV NS5A replication complex inhibitorsDonald R O'Boyle Ii, Jin-Hua Sun, Peter T Nower, et al.
Angewandte Chemie (International Ed. in English)|September 14, 2018
A General Amino Acid Synthesis Enabled by Innate Radical Cross-CouplingShengyang Ni, Alberto F Garrido-Castro, Rohan R Merchant, et al.
Journal of Medicinal Chemistry|February 22, 2020
Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase InhibitorsGuo Li, Nicholas A Meanwell, Mark R Krystal, et al.
Pageof 6